As of 2024-12-12, the EV/EBITDA ratio of ImmunoGen Inc (IMGN) is -105.37. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. IMGN's latest enterprise value is 8,216.60 mil USD. IMGN's TTM EBITDA according to its financial statements is -77.98 mil USD. Dividing these 2 quantities gives us the above IMGN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.7x - 17.4x | 16.0x |
| Forward P/E multiples | 15.7x - 21.4x | 15.8x |
| Fair Price | (2.58) - (3.03) | (2.62) |
| Upside | -108.3% - -109.7% | -108.4% |
| Date | EV/EBITDA |